THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL

Authors
QUIRT I COUTURE F PICHETTE R OLWENY C WHITE D KING M SAWKA C HUAN S CLINCH J LAU C
Citation
I. Quirt et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL, Blood, 88(10), 1996, pp. 1378-1378
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
1378 - 1378
Database
ISI
SICI code
0006-4971(1996)88:10<1378:TROR(I>2.0.ZU;2-I